Salim I Khakoo

6PUBLICATIONS
19CO-AUTHORS
Solid tumoursAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 13, 2026
CD40L and IL-4 lymph node-associated signals protect B cells from rituximab-induced ADCC via KIR and NKG2A.

Lara V Graham, Russell B Foxall, Margaret Ashton-Key

|Sep 22, 2025
CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axis.

Lara V Graham, Ludmila Horehajova, Marco V Haselager

|Jan 26, 2025
Modeling the response to interleukin-21 to inform natural killer cell immunotherapy.

Indrani Nayak, Rosalba Biondo, William C Stewart

|Aug 29, 2024
NK Cells in the Lymph Nodes and Their Role in Anti-Tumour Immunity.

Lara V Graham, Salim I Khakoo, Matthew D Blunt

|Aug 23, 2024
The nuclear export protein XPO1 provides a peptide ligand for natural killer cells.

Matthew D Blunt, Hayden Fisher, Ralf B Schittenhelm

Pageof 1